Search research articles
Contact Us
Filters
Showing results (141-150 of 171) with videos related to
Page
of 18
Sort By:
The Canadian Journal of Cardiology
|
August 14, 2025
Early Hemodynamic Performance of the SAPIEN 3 Ultra Resilia and Evolut Valves: A Propensity-Matched Analysis
Marisa Avvedimento, Silvia Mas-Peiro, Suleman Aktaa, et al.
JAMA Cardiology
|
June 24, 2026
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis
Andrea Zito, Antonio Landi, Deepak L Bhatt, et al.
European Heart Journal
|
December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
Francesco Costa, Claudio Montalto, Mattia Branca, et al.
Structural Heart : the Journal of the Heart Team
|
July 24, 2025
Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women
Giulia Masiero, Anna Franzone, Valeria Paradies, et al.
American Heart Journal
|
August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI
Raffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Journal of the American College of Cardiology
|
July 5, 2023
P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
Felice Gragnano, Davide Cao, Leah Pirondini, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi, Mattia Branca, Anna Franzone, et al.
BMJ (Clinical Research Ed.)
|
June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Journal of the American College of Cardiology
|
February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, Roxana Mehran, Mattia Branca, et al.
BMJ Open
|
March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 171) with videos related to
Sort By:
Page
of 18
The Canadian Journal of Cardiology
|
August 14, 2025
Early Hemodynamic Performance of the SAPIEN 3 Ultra Resilia and Evolut Valves: A Propensity-Matched Analysis
Marisa Avvedimento, Silvia Mas-Peiro, Suleman Aktaa, et al.
JAMA Cardiology
|
June 24, 2026
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis
Andrea Zito, Antonio Landi, Deepak L Bhatt, et al.
European Heart Journal
|
December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
Francesco Costa, Claudio Montalto, Mattia Branca, et al.
Structural Heart : the Journal of the Heart Team
|
July 24, 2025
Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women
Giulia Masiero, Anna Franzone, Valeria Paradies, et al.
American Heart Journal
|
August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI
Raffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Journal of the American College of Cardiology
|
July 5, 2023
P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
Felice Gragnano, Davide Cao, Leah Pirondini, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi, Mattia Branca, Anna Franzone, et al.
BMJ (Clinical Research Ed.)
|
June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Journal of the American College of Cardiology
|
February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, Roxana Mehran, Mattia Branca, et al.
BMJ Open
|
March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Page
of 18